Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-007648
Filing Date
2017-10-27
Accepted
2017-10-27 16:33:56
Documents
74
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bivv-20170930x10q.htm 10-Q 2017855
2 EX-10.1 bivv-20170930ex1017a9742.htm EX-10.1 9270
3 EX-31.1 bivv-20170930ex3116046ad.htm EX-31.1 12516
4 EX-31.2 bivv-20170930ex31269726d.htm EX-31.2 12864
5 EX-32.1 bivv-20170930ex321cf2ff2.htm EX-32.1 15058
6 GRAPHIC bivv20170930x10q001.jpg GRAPHIC 16846
7 GRAPHIC bivv20170930x10q002.jpg GRAPHIC 12603
8 GRAPHIC bivv20170930x10q003.jpg GRAPHIC 13562
9 GRAPHIC bivv20170930x10q004.jpg GRAPHIC 13795
10 GRAPHIC bivv20170930x10q005.jpg GRAPHIC 14037
  Complete submission text file 0001558370-17-007648.txt   7327457

Data Files

Seq Description Document Type Size
11 EX-101.INS bivv-20170930.xml EX-101.INS 1571412
12 EX-101.SCH bivv-20170930.xsd EX-101.SCH 45719
13 EX-101.CAL bivv-20170930_cal.xml EX-101.CAL 64404
14 EX-101.DEF bivv-20170930_def.xml EX-101.DEF 160309
15 EX-101.LAB bivv-20170930_lab.xml EX-101.LAB 442255
16 EX-101.PRE bivv-20170930_pre.xml EX-101.PRE 318119
Mailing Address 225 2ND AVENUE WALTHAM MA 02451
Business Address 225 2ND AVENUE WALTHAM MA 02451 781-663-4400
Bioverativ Inc. (Filer) CIK: 0001681689 (see all company filings)

EIN.: 813461310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37859 | Film No.: 171159820
SIC: 2834 Pharmaceutical Preparations